Clinical Trials Arena on MSN

Axsome begins Phase III AXS-14 FORWARD trial for fibromyalgia management

Axsome Therapeutics has initiated the FORWARD Phase III trial evaluating AXS-14 for the management of fibromyalgia, with the ...

New Randomized Trial Shows Promising Cognitive Gains in Long COVID Brain Fog Using Home-Based Light Therapy

Vielight Neuro RX Gamma device and irradiation configuration used in the randomized, double-blind, sham-controlled trial. The ...
Medscape

D-Mannose Fails to Prevent Urinary Tract Infections in Women

D-Mannose is often recommended for the prevention of urinary tract infections. The results of a randomized, double-blind study from the United Kingdom now cast doubt on the effectiveness of the simple ...
Lupus Foundation of America

New Research Explores Efficacy of Belimumab and Rituximab Combination Therapy for Systemic Lupus Erythematosus

In a new phase 3, double-blind study, researchers explored the efficacy and safety of combination therapy using subcutaneous (SC) belimumab and rituximab for the treatment of active systemic lupus ...
The Manila Times

PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVI…

PridCor Therapeutics, a clinical-stage biopharmaceutical company developing antiviral therapies for infection-associated ...